vimarsana.com
Home
Live Updates
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk) | Proteins and Peptides
Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk)
Related Keywords
Illinois ,
United States ,
Chicago ,
Chandramauli Rawal ,
Chintu Patel ,
Kashiv Biosciences ,
Drug Administration ,
I Amneal Pharmaceuticals Inc ,
Company Biologics License Application ,
United Statesi May ,
Amneal Pharmaceuticals ,
Biologics License Application ,
Co Chief Executive ,
Chief Operating Officer ,
Acute Myeloid Leukemia ,
Biologics ,
Protein ,
Therapeutic Protein ,
Peptide ,
Recombinant ,
Synthetic ,
Biosimilar ,
Biogeneric ,
Biosuperior ,
Binding Proteins ,